Abiopharma

🔍 Wai Conrad (Executive)

Company: CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Sold 23,463 shares of Class A Common Stock at $2.04 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,169,914.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-15 | Code: H | nature_of_ownership: By Trust. | shares_owned_after: 1,610,482.00 | Footnotes: F2

Footnotes:

• F1: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.
• F2: Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.